(MSCI) MSCI - Overview
Stock: Indexes, Analytics, Esg, Real-Estate
| Risk 5d forecast | |
|---|---|
| Volatility | 30.6% |
| Relative Tail Risk | -8.43% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.26 |
| Alpha | -20.24 |
| Character TTM | |
|---|---|
| Beta | 0.792 |
| Beta Downside | 0.925 |
| Drawdowns 3y | |
|---|---|
| Max DD | 25.99% |
| CAGR/Max DD | -0.03 |
EPS (Earnings per Share)
Revenue
Description: MSCI MSCI January 29, 2026
MSCI Inc. (NYSE:MSCI) delivers decision-support tools for the global investment community through four primary segments: Index, Analytics, ESG & Climate, and Private Assets/Capital Solutions. The Index segment supplies benchmarks for ETFs, mutual funds, derivatives and licensing of the GICS classification system; the Analytics segment offers risk-management, performance-attribution and data-consolidation services, including HedgePlatform for hedge-fund risk monitoring; the ESG & Climate segment provides ratings, research and compliance tools as regulators tighten sustainability disclosures; and the Private Assets segment furnishes data, benchmarks and workflow solutions for real-estate, infrastructure and other private-capital investments.
Recent performance indicators show MSCI’s revenue expanding to roughly $2.3 billion in FY 2024, a 6% year-over-year increase driven largely by higher licensing fees in the Index business (up ~10% as ETF assets surpass $10 trillion) and accelerated adoption of ESG data services, which now represent about 22% of total revenue. The company’s annual recurring revenue (ARR) stands near $3.5 billion, and operating margins have stabilized around 30%, reflecting the scalability of its SaaS-based offerings.
Key macro drivers include the continued growth of ESG-aligned capital-global ESG assets under management exceeded $50 trillion in 2023-and the expanding demand for transparent, climate-risk analytics across institutional portfolios, both of which reinforce MSCI’s strategic positioning. For a deeper dive into MSCI’s valuation metrics, the ValueRay platform offers a concise, data-rich snapshot.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 1.20b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.27 > 0.02 and ΔFCF/TA 0.92 > 1.0 |
| NWC/Revenue: -5.90% < 20% (prev -8.46%; Δ 2.56% < -1%) |
| CFO/TA 0.28 > 3% & CFO 1.59b > Net Income 1.20b |
| Net Debt (5.80b) to EBITDA (1.92b): 3.03 < 3 |
| Current Ratio: 0.90 > 1.5 & < 3 |
| Outstanding Shares: last quarter (77.3m) vs 12m ago -1.37% < -2% |
| Gross Margin: 82.44% > 18% (prev 0.82%; Δ 8162 % > 0.5%) |
| Asset Turnover: 56.23% > 50% (prev 52.45%; Δ 3.78% > 0%) |
| Interest Coverage Ratio: 8.12 > 6 (EBITDA TTM 1.92b / Interest Expense TTM 209.9m) |
Altman Z'' 5.62
| A: -0.03 (Total Current Assets 1.64b - Total Current Liabilities 1.83b) / Total Assets 5.70b |
| B: 0.95 (Retained Earnings 5.43b / Total Assets 5.70b) |
| C: 0.31 (EBIT TTM 1.70b / Avg Total Assets 5.57b) |
| D: 0.64 (Book Value of Equity 5.38b / Total Liabilities 8.36b) |
| Altman-Z'' Score: 5.62 = AAA |
Beneish M -2.99
| DSRI: 1.10 (Receivables 986.7m/820.7m, Revenue 3.13b/2.86b) |
| GMI: 0.99 (GM 82.44% / 81.99%) |
| AQI: 0.94 (AQ_t 0.68 / AQ_t-1 0.72) |
| SGI: 1.10 (Revenue 3.13b / 2.86b) |
| TATA: -0.07 (NI 1.20b - CFO 1.59b) / TA 5.70b) |
| Beneish M-Score: -2.99 (Cap -4..+1) = A |
What is the price of MSCI shares?
Over the past week, the price has changed by -7.72%, over one month by -10.96%, over three months by -9.80% and over the past year by -7.63%.
Is MSCI a buy, sell or hold?
- StrongBuy: 7
- Buy: 5
- Hold: 6
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the MSCI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 678.2 | 29.9% |
| Analysts Target Price | 678.2 | 29.9% |
| ValueRay Target Price | 529.4 | 1.4% |
MSCI Fundamental Data Overview February 12, 2026
P/E Forward = 26.3158
P/S = 12.2699
P/EG = 1.768
Revenue TTM = 3.13b USD
EBIT TTM = 1.70b USD
EBITDA TTM = 1.92b USD
Long Term Debt = 6.20b USD (from longTermDebt, last quarter)
Short Term Debt = 27.7m USD (from shortTermDebt, two quarters ago)
Debt = 6.31b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.80b USD (from netDebt column, last quarter)
Enterprise Value = 44.25b USD (38.46b + Debt 6.31b - CCE 515.3m)
Interest Coverage Ratio = 8.12 (Ebit TTM 1.70b / Interest Expense TTM 209.9m)
EV/FCF = 28.57x (Enterprise Value 44.25b / FCF TTM 1.55b)
FCF Yield = 3.50% (FCF TTM 1.55b / Enterprise Value 44.25b)
FCF Margin = 49.42% (FCF TTM 1.55b / Revenue TTM 3.13b)
Net Margin = 38.36% (Net Income TTM 1.20b / Revenue TTM 3.13b)
Gross Margin = 82.44% ((Revenue TTM 3.13b - Cost of Revenue TTM 550.4m) / Revenue TTM)
Gross Margin QoQ = 82.57% (prev 83.30%)
Tobins Q-Ratio = 7.76 (Enterprise Value 44.25b / Total Assets 5.70b)
Interest Expense / Debt = 1.01% (Interest Expense 63.6m / Debt 6.31b)
Taxrate = 26.79% (104.2m / 388.8m)
NOPAT = 1.25b (EBIT 1.70b * (1 - 26.79%))
Current Ratio = 0.90 (Total Current Assets 1.64b / Total Current Liabilities 1.83b)
Debt / Equity = -2.38 (negative equity) (Debt 6.31b / totalStockholderEquity, last quarter -2.65b)
Debt / EBITDA = 3.03 (Net Debt 5.80b / EBITDA 1.92b)
Debt / FCF = 3.74 (Net Debt 5.80b / FCF TTM 1.55b)
Total Stockholder Equity = -1.60b (last 4 quarters mean from totalStockholderEquity)
RoA = 21.57% (Net Income 1.20b / Total Assets 5.70b)
RoE = -74.96% (negative equity) (Net Income TTM 1.20b / Total Stockholder Equity -1.60b)
RoCE = 37.06% (EBIT 1.70b / Capital Employed (Equity -1.60b + L.T.Debt 6.20b))
RoIC = 34.77% (NOPAT 1.25b / Invested Capital 3.59b)
WACC = 7.69% (E(38.46b)/V(44.77b) * Re(8.83%) + D(6.31b)/V(44.77b) * Rd(1.01%) * (1-Tc(0.27)))
Discount Rate = 8.83% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.40%
[DCF Debug] Terminal Value 80.84% ; FCFF base≈1.50b ; Y1≈1.69b ; Y5≈2.28b
Fair Price DCF = 490.0 (EV 41.80b - Net Debt 5.80b = Equity 36.00b / Shares 73.5m; r=7.69% [WACC]; 5y FCF grow 14.83% → 2.90% )
EPS Correlation: 96.98 | EPS CAGR: 12.66% | SUE: 0.93 | # QB: 2
Revenue Correlation: 98.82 | Revenue CAGR: 10.80% | SUE: -0.16 | # QB: 0
EPS next Quarter (2026-03-31): EPS=4.43 | Chg30d=-0.052 | Revisions Net=-3 | Analysts=12
EPS current Year (2026-12-31): EPS=19.46 | Chg30d=+0.105 | Revisions Net=+6 | Growth EPS=+12.6% | Growth Revenue=+10.3%
EPS next Year (2027-12-31): EPS=22.03 | Chg30d=+0.251 | Revisions Net=+11 | Growth EPS=+13.2% | Growth Revenue=+8.7%